Teddy Pan, MD
Dermatopathology · Colonie, NYNPI 1609847979
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 31.0% of the total.
Across 113 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$711
- AbbVie$218
- Sun Pharmaceutical Industries Inc.$218
- Novartis$175
- Sanofi$146
- Regeneron Healthcare Solutions, Inc.$122
- plus $705 from 15 others
What the payments were for
- Food & beverage$2,12292%
- Education$1738%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $711 |
| AbbVie | 9 | $218 |
| Sun Pharmaceutical Industries Inc. | 10 | $218 |
| Novartis | 8 | $175 |
| Sanofi | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 6 | $122 |
| LEO Pharma Inc. | 4 | $108 |
| E.r. Squibb & Sons, L.L.C. | 5 | $93 |
| Pfizer | 4 | $86 |
| Amgen(2 entities) | 5 | $74 |
| Lilly USA, LLC | 3 | $58 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Galderma Laboratories, L.p. | 2 | $34 |
| AstraZeneca | 1 | $31 |
| Mission Pharmacal Company | 1 | $23 |
| Prugen, Inc. Pharmaceuticals | 2 | $21 |
| UCB, Inc. | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Organon | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$2,295 in reported general payments places this provider in the 85th percentile of 44 dermatopathology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 53 | $201,299 |
| Fluorouracil | 99 | $5,344 |
| Tacrolimus | 18 | $3,324 |
| Clobetasol Propionate | 55 | $2,752 |
| Triamcinolone Acetonide | 160 | $2,439 |
| Metronidazole | 40 | $2,176 |
| Clindamycin Phosphate | 54 | $2,131 |
| Ketoconazole | 81 | $1,522 |
| Fluocinonide | 17 | $1,250 |
| Imiquimod | 23 | $853 |
| Desonide | 13 | $770 |
| Ammonium Lactate | 18 | $452 |
| ValacyclovirValacyclovir Hcl | 19 | $385 |
| Mometasone Furoate | 19 | $368 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 19 | $363 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Colonie
- Alejandro GruNew York$242K
- Scott SandersNew City$33K
- Ramsay FarahSyracuse$5K
- Avi BittermanWoodmere$3K
- Miriam CasalJackson Heights$2K
- Paul ChuTarrytown$2K
- Michael MillerPort Chester$1K
- Radha MikkilineniGarden City$1K
- Apoorva TrivediDepew$1K
- Jisun ChaNew York$756
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.